OptimizeRx Corp Quarterly Deferred Federal Income Tax Expense (Benefit) in USD from Q2 2010 to Q1 2014
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
OptimizeRx Corp annual/quarterly Deferred Federal Income Tax Expense (Benefit) history and growth rate from Q2 2010 to Q1 2014.
- OptimizeRx Corp Deferred Federal Income Tax Expense (Benefit) for the quarter ending March 31, 2014 was $0.000.
- OptimizeRx Corp Deferred Federal Income Tax Expense (Benefit) for the twelve months ending March 31, 2014 was $0.000.
- OptimizeRx Corp annual Deferred Federal Income Tax Expense (Benefit) for 2023 was $16.7M.
- OptimizeRx Corp annual Deferred Federal Income Tax Expense (Benefit) for 2013 was $0.000.
- OptimizeRx Corp annual Deferred Federal Income Tax Expense (Benefit) for 2012 was $0.000.
Deferred Federal Income Tax Expense (Benefit), Trailing 12 Months (USD)
Deferred Federal Income Tax Expense (Benefit), Quarterly (USD)